Related Experiment Video
Updated: Jan 24, 2026
08:11
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
Published on: November 14, 2016
11.5K
Long-term disability progression of pediatric-onset multiple sclerosis
Kyla A McKay1, Jan Hillert1, Ali Manouchehrinia2
1From the Department of Clinical Neuroscience (K.A.M., J.H., A.M.), Karolinska Institutet; and Centre for Molecular Medicine (A.M.), Karolinska Hospital, Stockholm, Sweden.
Neurology
|May 17, 2019
Summary
Pediatric-onset multiple sclerosis (MS) patients progress to disability milestones slower but at a younger age than adults. Factors like disease course and relapse rate influence progression in pediatric MS.
Area of Science:
- Neurology
- Clinical Research
- Epidemiology
Background:
- Multiple sclerosis (MS) affects individuals of all ages, with distinct onset groups including pediatric-onset MS (POMS) and adult-onset MS (AOMS).
- Understanding long-term disability progression is crucial for effective management strategies in different MS populations.
Purpose of the Study:
- To evaluate and compare the long-term disability progression between POMS and AOMS.
- To identify factors associated with disability progression in POMS.
Main Methods:
- Retrospective cohort study utilizing prospectively collected data from the Swedish MS Registry.
- Kaplan-Meier analysis and Cox proportional hazards regression were used to compare disability milestones (Expanded Disability Status Scale [EDSS] 3, 4, and 6) between POMS and AOMS.
Main Results:
- A total of 12,482 individuals were analyzed, with 549 classified as POMS.
- POMS patients reached disability milestones later from disease onset but at a younger age compared to AOMS patients.
- Primary progressive course, higher initial relapse rates, and complete remission from the initial relapse were significantly associated with altered disability progression risk in POMS.
Conclusions:
- Pediatric-onset MS exhibits a distinct clinical course compared to adult-onset MS.
- These findings underscore the need for tailored treatment and management approaches for pediatric MS patients.
Related Concept Videos
01:29Intellectual Disability
693
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
693
01:25Learning Disabilities
583
Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
Dyslexia
Dyslexia is a...
583
01:05Long-term Depression
33.2K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.2K
02:07Tumor Progression
7.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.3K
01:49Multiple Allele Traits
38.0K
The Concept of Multiple Allelism
38.0K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214